CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • June 10th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • Delaware
Contract Type FiledJune 10th, 2019 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of June 7, 2019 (the “Effective Date”), is entered into by and between GTx, Inc., a Delaware corporation (“Parent”), Marc S. Hanover, as representative of the Holders (the “Holders’ Representative”), and Computershare Inc., as Rights Agent.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • April 30th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • Delaware
Contract Type FiledApril 30th, 2019 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [ · ], 2019 (the “Effective Date”), is entered into by and between GTx, Inc., a Delaware corporation (“Parent”), Marc S. Hanover, as representative of the Holders (the “Holders’ Representative”), and Computershare Inc., as Rights Agent.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • March 7th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 7th, 2019 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [ · ], 2019 (the “Effective Date”), is entered into by and between GTx, Inc., a Delaware corporation (“Parent”), Marc S. Hanover, as representative of the Holders (the “Holders’ Representative”), and Computershare Inc., as Rights Agent.